Rock-bottom prices don't always mean rock-bottom businesses. The stocks we're examining today have all touched their 52-week lows, creating a classic investor's dilemma: bargain opportunity or value trap?
While market timing can be an extremely profitable strategy, it has burned many investors and requires rigorous analysis - something we specialize in at StockStory. Keeping that in mind, here are two stocks where the poor sentiment is creating a buying opportunity and one facing legitimate challenges.
One Stock to Sell:
Dolby Laboratories (DLB)
One-Month Return: -5.5%
Known for its iconic "D" logo that appears before countless movies and TV shows, Dolby Laboratories (NYSE: DLB) designs and licenses audio and video technologies that enhance entertainment experiences in movies, TV shows, music, and other media.
Why Should You Sell DLB?
- Sales trends were unexciting over the last five years as its 2.1% annual growth was well below the typical software company
- Extended payback periods on sales investments suggest the company’s platform isn’t resonating enough to drive efficient sales conversions
- Costs have risen faster than its revenue over the last year, causing its operating margin to decline by 2 percentage points
Dolby Laboratories is trading at $58.15 per share, or 3.8x forward price-to-sales. If you’re considering DLB for your portfolio, see our FREE research report to learn more.
Two Stocks to Watch:
Allegion (ALLE)
One-Month Return: -8.7%
Allegion plc (NYSE: ALLE) is a provider of security products and solutions that keep people and assets safe and secure in various environments.
Why Do We Like ALLE?
- Healthy operating margin of 19.6% shows it’s a well-run company with efficient processes, and its operating leverage amplified its profits over the last five years
- Strong free cash flow margin of 14.5% enables it to reinvest or return capital consistently, and its growing cash flow gives it even more resources to deploy
- Stellar returns on capital showcase management’s ability to surface highly profitable business ventures
Allegion’s stock price of $134.37 implies a valuation ratio of 15.2x forward P/E. Is now a good time to buy? Find out in our full research report, it’s free.
Arthur J. Gallagher (AJG)
One-Month Return: -11%
Founded in 1927 and operating in approximately 130 countries through direct operations and correspondent networks, Arthur J. Gallagher (NYSE: AJG) provides insurance brokerage, reinsurance, consulting, and third-party claims settlement services to businesses and individuals worldwide.
Why Are We Bullish on AJG?
- Market share has increased this cycle as its 19.1% annual revenue growth over the last two years was exceptional
- Earnings growth has trumped its peers over the last five years as its EPS has compounded at 18.5% annually
- Impressive free cash flow profitability enables the company to fund new investments or reward investors with share buybacks/dividends
At $198.00 per share, Arthur J. Gallagher trades at 14.7x forward P/E. Is now the right time to buy? See for yourself in our comprehensive research report, it’s free.
High-Quality Stocks for All Market Conditions
ONE MORE THING: Top 5 Growth Stocks. The biggest stock winners almost always had one thing in common before they ran. Revenue growing like crazy. Meta. CrowdStrike. Broadcom. Our AI flagged all three. They returned 315%, 314%, and 455%, respectively.
Find out which 5 stocks it's flagging for this month - FREE. Get Our Top 5 Growth Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.
